Pharmacy market analysis, salary intelligence, and UK job trends. Data-driven insights from 13,147 pharmacies and 5.3M dispensing records.
A plain-English guide to Sciensus, HealthNet, Alcura and Lloyds Clinical — the pharmacies that deliver your specialist medicines.
A plain-English read of the Q4 2025/26 emergency-care data and where pharmacy fits into the picture.
A guide to the HST pathway: what it evaluates, what it has approved, and how patients reach these medicines.
Why some expensive medicines are available on the NHS with conditions attached, and what this means at the pharmacy counter.
Every winter surge brings parents of coughing infants to the pharmacy counter — here is what community pharmacy can usefully do, and where referral is non-negotiable.
Creatine, magnesium, omega-3, probiotics and the rest — a single landing page to navigate what the evidence supports and what it doesn't.
How the post-Windsor Framework mechanism keeps UK-licensed medicines flowing to Northern Ireland community pharmacy — and which products sit inside it.
The UK's first routinely commissioned gene-editing therapy is changing lifelong medication regimens — here is what to expect when a patient returns to your counter.
A short guide to the prescriptions, prophylaxis and red flags community pharmacy should expect when a CAR-T patient is discharged into the community.
Pregnancy, heavy menstrual bleeding, coeliac disease and vegetarian diets all drive iron deficiency differently — and community pharmacy choice should reflect that.
Specialist infant formulas on the ACBS list are community-pharmacy-dispensed NHS prescriptions — with indications, pathways and substitution rules of their own.
Gene, cell and tissue-engineered therapies are no longer confined to tertiary centres — community pharmacy teams increasingly see patients on aftercare pathways.
The seven-condition clinical pathway permits supply for some infections but retains referral for others — here's where pharmacists act and where they still send patients on.
The MHRA's April 2026 approval of a single-dose 7.2mg semaglutide pen adds a higher top-dose option for weight management — here's what community pharmacy needs to know.
Three cities within 70 miles of each other — but their pharmacy markets look very different.
PharmSee's analysis of NHSBSA dispensing data reveals that Birmingham's 142 community pharmacies average just £77,966 in annual dispensing revenue — nearly half the figure in Newcastle.
Three neighbouring cities with sharply different pharmacy profiles — from Leicester's high GP ratio to Derby's vacancy desert and Nottingham's revenue compression.
Birmingham has more pharmacies, more GPs, and a higher GP-to-pharmacy ratio — but lower revenue and far fewer vacancies than Manchester.
From £1.29 per dispensed item to £31.82 per New Medicine Service consultation, the NHS fee schedule shapes every aspect of community pharmacy economics.
Thirty miles apart, Sheffield and Leeds present strikingly different pharmacy economics — higher revenue in Sheffield, more diverse hiring in Leeds.
Some independent pharmacies generate three to four times the city average in dispensing revenue. PharmSee's data points to location, services, and GP relationships as the key drivers.
In eight of nine English cities measured, independent pharmacies out-earn chain branches. Nottingham is the exception — and the reasons point to a structurally different market.
With an average dispensing revenue of £160,122 per branch, Newcastle's 44 active independent pharmacies lead all nine cities measured by PharmSee — 63% above the local chain average.
With 142 pharmacies but only 47 vacancies — 64% from NHS Jobs — Birmingham's independent pharmacy sector appears to hire through channels invisible to online job boards.
PharmSee's analysis of dispensing revenue across nine urban centres finds independent pharmacies averaging higher NHSBSA-reported revenue per branch than major chains in most measured markets.
Eight of 26 pharmacies within three miles of Exeter city centre have no dispensing activity in the latest NHSBSA data — the highest rate PharmSee has measured in any English city.
PharmSee's cross-city analysis of dispensing revenue reveals that independent pharmacies consistently generate higher revenue per active branch than major chain operators.
Newcastle records the highest dispensing revenue per active pharmacy branch of any English city PharmSee has measured — despite having one of the lowest GP-to-pharmacy ratios.
The two largest cities in Devon record the highest GP-to-pharmacy ratios of any measured English city, pointing to structural demand in the South West.
From £66,788 per branch in London to £141,431 in Newcastle — dispensing revenue tracks the GP-to-pharmacy ratio, with notable exceptions.
At 1.49 GP practices per pharmacy, Plymouth's community pharmacies handle above-average prescription volume — and earn above-average revenue.
With 292 registered pharmacies and the lowest revenue per branch of any major English city, London's pharmacy market presents a paradox of scale and competition.
With 85 registered pharmacies, 67 GP practices, and a 0.79:1 ratio, Nottingham's pharmacy market is one of the most competitive in England.
Between 16% and 32% of registered pharmacy branches show zero dispensing revenue in NHSBSA data, depending on the city. The gap matters for anyone using branch counts to assess pharmacy access.
From 54% in Exeter to 78% in Sunderland, the proportion of independently owned pharmacies differs dramatically between English cities — with implications for hiring, competition, and market structure.
With 106 pharmacies, 150 GP practices, and the highest GP-to-pharmacy ratio PharmSee has measured in a major English city, Liverpool's pharmacy market has distinctive characteristics.
Similar branch counts, different revenue profiles and distinct chain dynamics make the North West's two largest cities a revealing pharmacy comparison.
All six Rowlands Pharmacy branches within three miles of Oxford city centre record no dispensing activity in the latest NHSBSA data — the most concentrated blank in any city PharmSee has measured.
Excluding zero-revenue register entries shifts GP-to-pharmacy ratios by 15-30% across English cities — enough to change planning decisions.
108 registered pharmacies, 91 actively dispensing, and a job market dominated by independents and regional chains.
100 registered pharmacies, 79 actively dispensing, and 11 legacy Lloyds entries — Sheffield's pharmacy market by the numbers.
Former Lloyds branches closed in 2023 still appear on the NHSBSA contractor register in 2026 — inflating pharmacy counts across England.
Sunderland pharmacies average £158,000 in dispensing revenue — nearly double Oxford's figure. Area deprivation explains much of the gap.
One city earns double per pharmacy — deprivation, GP ratios, and the Lloyds exit explain why.
Separated by 12 miles with near-identical GP-to-pharmacy ratios, the two cities have surprisingly different market structures — from chain presence to per-pharmacy revenue.
From £158,000 in Sunderland to £64,000 in Oxford, average per-pharmacy dispensing income varies by more than 2:1 across England's cities.
Across 13 English cities, 15-27% of NHS-registered pharmacies show no dispensing activity — distorting GP-to-pharmacy ratios and complicating planning decisions.
At 0.78:1, Sunderland has more pharmacies per GP practice than most English cities — but 15 of 55 branches show no dispensing activity, the highest rate PharmSee has measured.
Stoke's 74 registered pharmacies serve 66 GP practices, but 14 branches show no dispensing activity — nine of them former chain sites still on the NHS register.
With 40 pharmacies for 35 GP practices, Norwich has one of the lower GP-to-pharmacy ratios among English mid-size cities — but eight branches show no dispensing activity.